Rockefeller Capital Management
ABEO icon

Rockefeller Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Rockefeller Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.6K Hold
1,250
– – ﹤0.01% 4206
2025
Q4 		$6.59K Hold
1,250
– – ﹤0.01% 3977
2025
Q3 		$6.6K Buy
+1,250
New +$7.93K ﹤0.01% 3794
2023
Q1 		– Sell
-1,500
Closed -$4K – 1975
2022
Q4 		$4K Buy
+1,500
New +$5.61K ﹤0.01% 3359
2020
Q4 		– Sell
-160
Closed -$4K – 2830
2020
Q3 		$4K Buy
+160
New +$10.1K ﹤0.01% 2258

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rockefeller Capital Management's ABEO Position: Q1 2026 in Review

Rockefeller Capital Management held its Abeona Therapeutics (ABEO) position steady in Q1 2026 at 1,250 shares worth $5.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4206.

Rockefeller Capital Management first reported a position in ABEO in Q3 2020 and has held it in 5 quarters since. The position peaked at $6.6K in Q3 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Rockefeller Capital Management held 1,250 shares of Abeona Therapeutics worth $5.6K as of Q1 2026.
  • Rockefeller Capital Management left its Abeona Therapeutics share count unchanged in Q1 2026.
  • Abeona Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4206 holding.
  • Rockefeller Capital Management first reported a position in Abeona Therapeutics in Q3 2020 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Abeona Therapeutics position peaked at $6.6K in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.